BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rozen-Zvi B, Yahav D, Agur T, Zingerman B, Ben-Zvi H, Atamna A, Tau N, Mashraki T, Nesher E, Rahamimov R. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study. Clin Microbiol Infect 2021;27:1173.e1-4. [PMID: 33957273 DOI: 10.1016/j.cmi.2021.04.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Ohki Y, Kawabe M, Yamamoto I, Katsumata H, Nakada Y, Kobayashi A, Urabe F, Miki J, Yamada H, Kimura T, Matsuo N, Tanno Y, Horino T, Ohkido I, Yamamoto H, Yokoo T. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients. Front Microbiol 2022;13:922042. [PMID: 35756063 DOI: 10.3389/fmicb.2022.922042] [Reference Citation Analysis]
2 Terrec F, Jouve T, Malvezzi P, Janbon B, Naciri Bennani H, Rostaing L, Noble J. Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response. J Clin Med 2021;10:5159. [PMID: 34768680 DOI: 10.3390/jcm10215159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chantasrisawad N, Puthanakit T, Tangsathapornpong A, Techasaensiri C, Phongsamart W, Suwanpakdee D, Jaruampornpan P, Sophonphan J, Suntarattiwong P, Chotpitayasunondh T. Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases. Vaccines 2022;10:871. [DOI: 10.3390/vaccines10060871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shem-Tov N, Yerushalmi R, Danylesko I, Litachevsky V, Levy I, Olmer L, Lusitg Y, Avigdor A, Nagler A, Shimoni A, Rahav G. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients. Br J Haematol 2021. [PMID: 34713441 DOI: 10.1111/bjh.17918] [Reference Citation Analysis]
5 Balsby D, Nilsson AC, Möller S, Lindvig SO, Davidsen JR, Abazi R, Poulsen MK, Holden IK, Justesen US, Bistrup C, Johansen IS. Determinants of Antibody Response to a Third SARS-CoV-2 mRNA Vaccine Dose in Solid Organ Transplant Recipients: Results from the Prospective Cohort Study COVAC-Tx. Vaccines 2022;10:565. [DOI: 10.3390/vaccines10040565] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Niessen F, Mirjam Knol J, Susan Hahné J, study group V, Bonten M, Bruijning-verhagen P. Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: a test-negative case-control study. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.06.011] [Reference Citation Analysis]
7 Mehrabi Nejad MM, Shobeiri P, Dehghanbanadaki H, Tabary M, Aryannejad A, Haji Ghadery A, Shabani M, Moosaie F, SeyedAlinaghi S, Rezaei N. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis. Virol J 2022;19:132. [PMID: 35941646 DOI: 10.1186/s12985-022-01858-3] [Reference Citation Analysis]
8 Yahav D, Rozen-Zvi B, Mashraki T, Atamna A, Ben-Zvi H, Bar-Haim E, Rahamimov R. Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study). BMJ Open 2021;11:e055611. [PMID: 34635537 DOI: 10.1136/bmjopen-2021-055611] [Reference Citation Analysis]
9 Affeldt P, Koehler FC, Brensing KA, Adam V, Burian J, Butt L, Gies M, Grundmann F, Hinrichs S, Johannis W, Kalisch N, Meyer-Delpho M, Oehm S, Platen E, Schöler C, Heger E, Steger G, Stippel D, Ziegelhöfer A, Benzing T, Klein F, Kurschat C, Müller RU, Cristanziano VD. Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients. Microorganisms 2021;10:4. [PMID: 35056453 DOI: 10.3390/microorganisms10010004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rodríguez-Cubillo B, Moreno de la Higuera MA, Pérez-Flores I, Calvo Romero N, Aiffil AS, Arribi Vilela A, Peix B, Huertas S, Juez A, Sanchez-Fructuoso AI. Clinical Effectiveness of SARS-CoV-2 Vaccination in Renal Transplant Recipients. Antibody Levels Impact in Pneumonia and Death. Transplantation 2022. [PMID: 35859270 DOI: 10.1097/TP.0000000000004261] [Reference Citation Analysis]
11 Ducloux D, Courivaud C. Should vaccination against COVID-19 be mandated in patients on the transplant waiting list? Kidney Int 2021:S0085-2538(21)00736-5. [PMID: 34339748 DOI: 10.1016/j.kint.2021.07.017] [Reference Citation Analysis]
12 Lim SY, Yoon Y, Kim JY, Tak E, Song G, Kim S, Lee S. Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients. Immune Netw 2022;22:e24. [DOI: 10.4110/in.2022.22.e24] [Reference Citation Analysis]
13 Chemaly RF. The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings. Clin Microbiol Infect 2021:S1198-743X(21)00376-1. [PMID: 34256140 DOI: 10.1016/j.cmi.2021.07.003] [Reference Citation Analysis]
14 Firinu D, Perra A, Campagna M, Littera R, Fenu G, Meloni F, Cipri S, Sedda F, Conti M, Miglianti M, Costanzo G, Secci M, Usai G, Carta MG, Cappai R, Orrù G, Del Giacco S, Coghe F, Chessa L. Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination. Clin Exp Med 2021. [PMID: 34741188 DOI: 10.1007/s10238-021-00771-3] [Reference Citation Analysis]
15 Yahav D, Rahamimov R, Mashraki T, Ben-Dor N, Steinmetz T, Agur T, Zingerman B, Herman-Edelstein M, Lichtenberg S, Ben-Zvi H, Bar-Haim E, Cohen H, Rotem S, Elia U, Margalit I, Zvi BR. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study. Transpl Int 2022;35:10204. [PMID: 35529596 DOI: 10.3389/ti.2022.10204] [Reference Citation Analysis]
16 Li J, Ayada I, Wang Y, den Hoed CM, Kamar N, Peppelenbosch MP, de Vries AC, Li P, Pan Q. Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis. Transplantation 2022. [PMID: 35761439 DOI: 10.1097/TP.0000000000004256] [Reference Citation Analysis]
17 Toapanta N, Bestard O, Soler MJ. SARS CoV-2 vaccination in patients receiving kidney replacement therapies: where are we now with the protective immune response? Nephrol Dial Transplant 2021:gfab227. [PMID: 34289072 DOI: 10.1093/ndt/gfab227] [Reference Citation Analysis]
18 Carruthers JE, Wells J, Gupta A, Kallon D, Cox A, Pina N, Yaqoob MM, Rajakariar R. Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Involvement. Front Med 2022;8:817845. [DOI: 10.3389/fmed.2021.817845] [Reference Citation Analysis]
19 Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Eliakim-Raz N, Yahav D, Abed G, Abuhazira M, Barac YD, Mats I, Shochat T, Aravot D, Kornowski R, Ben-Gal T. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients. ESC Heart Fail 2022. [PMID: 34981657 DOI: 10.1002/ehf2.13798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Manuel O. COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary. Clin Microbiol Infect 2021;27:1070-1. [PMID: 34153456 DOI: 10.1016/j.cmi.2021.06.018] [Reference Citation Analysis]
21 Markewitz R, Pauli D, Dargvainiene J, Steinhagen K, Engel S, Herbst V, Zapf D, Krüger C, Sharifzadeh S, Schomburg B, Leypoldt F, Rupp J, Görg S, Junker R, Wandinger KP. The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273. Clin Microbiol Infect 2021:S1198-743X(21)00496-1. [PMID: 34547457 DOI: 10.1016/j.cmi.2021.09.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
22 Manothummetha K, Chuleerarux N, Sanguankeo A, Kates OS, Hirankarn N, Thongkam A, Dioverti-Prono MV, Torvorapanit P, Langsiri N, Worasilchai N, Moonla C, Plongla R, Garneau WM, Chindamporn A, Nissaisorakarn P, Thaniyavarn T, Nematollahi S, Permpalung N. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis. JAMA Netw Open 2022;5:e226822. [PMID: 35412626 DOI: 10.1001/jamanetworkopen.2022.6822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
23 Regele F, Heinzel A, Hu K, Raab L, Eskandary F, Faé I, Zelzer S, Böhmig GA, Bond G, Fischer G, Oberbauer R, Reindl-Schwaighofer R. Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot Study. Front Med (Lausanne) 2022;9:914424. [PMID: 35755078 DOI: 10.3389/fmed.2022.914424] [Reference Citation Analysis]
24 Giannella M, Righi E, Pascale R, Rinaldi M, Caroccia N, Gamberini C, Palacios-baena ZR, Caponcello G, Morelli MC, Tamè M, Busutti M, Comai G, Potena L, Salvaterra E, Feltrin G, Cillo U, Gerosa G, Cananzi M, Piano S, Benetti E, Burra P, Loy M, Furian L, Zaza G, Onorati F, Carraro A, Gastaldon F, Nordio M, Kumar-singh S, Abedini M, Boffetta P, Rodríguez-baño J, Lazzarotto T, Viale P, Tacconelli E; on behalf of The ORCHESTRA Study Group Workpackage. Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort. Microorganisms 2022;10:1021. [DOI: 10.3390/microorganisms10051021] [Reference Citation Analysis]
25 Herzberg J, Vollmer T, Fischer B, Becher H, Becker AK, Honarpisheh H, Guraya SY, Strate T, Knabbe C. SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study. Vaccine 2021:S0264-410X(21)01555-3. [PMID: 34895938 DOI: 10.1016/j.vaccine.2021.11.081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
26 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
27 Filippidis P, Vionnet J, Manuel O, Mombelli M. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34854329 DOI: 10.1080/14787210.2022.2013808] [Reference Citation Analysis]
28 Tau N, Yahav D, Schneider S, Rozen-Zvi B, Abu Sneineh M, Rahamimov R. Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients. Am J Transplant 2021;21:2910-2. [PMID: 34043872 DOI: 10.1111/ajt.16700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 24.0] [Reference Citation Analysis]
29 Ferreira VH, Marinelli T, Ierullo M, Ku T, Hall VG, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients. J Infect Dis 2021:jiab542. [PMID: 34739078 DOI: 10.1093/infdis/jiab542] [Reference Citation Analysis]
30 Opsomer R, Kuypers D. COVID-19 and solid organ transplantation: Finding the right balance. Transplantation Reviews 2022;36:100710. [DOI: 10.1016/j.trre.2022.100710] [Reference Citation Analysis]
31 Hou YC, Lu KC, Kuo KL. The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review. Vaccines (Basel) 2021;9:885. [PMID: 34452010 DOI: 10.3390/vaccines9080885] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
32 Fernández-ruiz M. COVID-19 en receptores de trasplante renal: ¿qué hemos aprendido tras 18 meses de pandemia? Enferm Nefrol 2021;24:219-31. [DOI: 10.37551/s2254-28842021020] [Reference Citation Analysis]
33 de Boer SE, Berger SP, van Leer-Buter CC, Kroesen BJ, van Baarle D, Sanders JF. Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens. Transplantation 2022. [PMID: 35546527 DOI: 10.1097/TP.0000000000004177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Abu Shanap M, Sughayer M, Alsmadi O, Elzayat I, Al-nuirat A, Tbakhi A, Sultan I. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection. Front Immunol 2022;13:919762. [DOI: 10.3389/fimmu.2022.919762] [Reference Citation Analysis]
35 Moreno NF, Mcadams R, Goss JA, Galvan NTN. COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00366-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Sáez-Peñataro J, Torres F, Bartra J, Bascuas J, Vilella A, Tortajada M, Quesada S, González E, López-Suñé E, Castells A, Serrano S, Camacho C, Trilla A, Calvo G; VigilVacCOVID Group. Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study). BioDrugs 2022. [PMID: 35764768 DOI: 10.1007/s40259-022-00543-9] [Reference Citation Analysis]
37 Hod T, Ben-David A, Olmer L, Scott N, Ghinea R, Mor E, Levy I, Indenbaum V, Lustig Y, Grossman E, Rahav G. BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients. Transpl Int 2022;35:10239. [PMID: 35387393 DOI: 10.3389/ti.2022.10239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Al Jalali V, Scherzer S, Zeitlinger M. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines. Clin Microbiol Infect 2021:S1198-743X(21)00342-6. [PMID: 34192576 DOI: 10.1016/j.cmi.2021.06.022] [Reference Citation Analysis]
39 Chukwu CA, Mahmood K, Elmakki S, Gorton J, Kalra PA, Poulikakos D, Middleton R. Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre. PLoS One 2022;17:e0265130. [PMID: 35271655 DOI: 10.1371/journal.pone.0265130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
40 Swai J, Gui M, Long M, Wei Z, Hu Z, Liu S. Humoral and cellular immune response to severe acute respiratory syndrome coronavirus-2 vaccination in haemodialysis and kidney transplant patients. Nephrology (Carlton) 2021. [PMID: 34510645 DOI: 10.1111/nep.13974] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kumar N, Rana R, Rana DS, Gupta A, Sachdeva MP. SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review. Transplantology 2022;3:33-48. [DOI: 10.3390/transplantology3010004] [Reference Citation Analysis]
42 Loubet P, Wittkop L, Tartour E, Parfait B, Barrou B, Blay JY, Hourmant M, Lachâtre M, Laplaud DA, Laville M, Laviolle B, Lelievre JD, Morel J, Nguyen S, Spano JP, Terrier B, Thiebaut A, Viallard JF, Vrtovsnik F, de Lamballerie X, Launay O. A French cohort for assessing COVID-19 vaccine responses in specific populations. Nat Med 2021;27:1319-21. [PMID: 34253930 DOI: 10.1038/s41591-021-01435-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Cortés-Sarabia K, Gutiérrez-Torres M, Mendoza-Renteria EM, Leyva-Vázquez MA, Vences-Velázquez A, Hernández-Sotelo D, Beltrán-Anaya FO, Del Moral-Hernández O, Illades-Aguiar B. Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review. Vaccines (Basel) 2022;10:909. [PMID: 35746517 DOI: 10.3390/vaccines10060909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Chavarot N, Morel A, Leruez-Ville M, Vilain E, Divard G, Burger C, Serris A, Sberro-Soussan R, Martinez F, Amrouche L, Bererhi L, Lanternier F, Legendre C, Zuber J, Anglicheau D, Scemla A. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant 2021. [PMID: 34431207 DOI: 10.1111/ajt.16814] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 33.0] [Reference Citation Analysis]
45 Firinu D, Perra A, Campagna M, Littera R, Fenu G, Meloni F, Cipri S, Sedda F, Conti M, Miglianti M, Costanzo G, Secci M, Usai G, Carta MG, Cappai R, Orrù G, Del Giacco S, Coghe F, Chessa L. Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination. Clin Exp Med 2021. [PMID: 34741188 DOI: 10.1007/s10238-021-00771-3] [Reference Citation Analysis]
46 Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine. Infect Dis Ther 2021. [PMID: 34859359 DOI: 10.1007/s40121-021-00574-9] [Reference Citation Analysis]
47 Vaiciuniene R, Sitkauskiene B, Bumblyte IA, Dalinkeviciene E, Ziginskiene E, Bagdonas D, Augliene R, Petruliene K, Bagdziuniene I, Skarupskiene I, Stankuviene A, Sauseriene J, Macinskas S, Valius L. Immune Response after SARS-CoV-2 Vaccination in Kidney Transplant Patients. Medicina (Kaunas) 2021;57:1327. [PMID: 34946272 DOI: 10.3390/medicina57121327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Rashidi-Alavijeh J, Frey A, Passenberg M, Korth J, Zmudzinski J, Anastasiou OE, Saner FH, Jahn M, Lange CM, Willuweit K. Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience. Vaccines (Basel) 2021;9:738. [PMID: 34358154 DOI: 10.3390/vaccines9070738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Crane C, Phebus E, Ingulli E. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients. Pediatr Nephrol 2021. [PMID: 34522992 DOI: 10.1007/s00467-021-05256-9] [Reference Citation Analysis]
50 Granata S, Carratù P, Stallone G, Zaza G. mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis. Front Pharmacol 2021;12:710543. [PMID: 34497515 DOI: 10.3389/fphar.2021.710543] [Reference Citation Analysis]
51 Shmueli ES, Itay A, Margalit O, Berger R, Halperin S, Jurkowicz M, Levin EG, Levy I, Olmer L, Regev-Yochay G, Lustig Y, Rahav G. Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy - a single centre prospective study. Eur J Cancer 2021;157:124-31. [PMID: 34508994 DOI: 10.1016/j.ejca.2021.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Yeshurun M, Pasvolsky O, Shargian L, Yahav D, Ben-Zvi H, Rubinstein M, Sela-Navon M, Wolach O, Raanani P, Rozovski U. Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation. Clin Microbiol Infect 2021:S1198-743X(21)00606-6. [PMID: 34715348 DOI: 10.1016/j.cmi.2021.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
53 Kang JM, Lee J, Huh KH, Joo DJ, Lee JG, Kim HR, Kim HY, Lee M, Jung I, Kim MY, Kim S, Park Y, Kim MS. Matched Versus Mixed COVID-19 Vaccinations in Korean Solid Organ Transplant Recipients: An Observational Study. Transplantation 2022. [PMID: 35749755 DOI: 10.1097/TP.0000000000004241] [Reference Citation Analysis]
54 Moyon Q, Sterlin D, Miyara M, Anna F, Mathian A, Lhote R, Ghillani-Dalbin P, Breillat P, Mudumba S, de Alba S, Cohen-Aubart F, Haroche J, Pha M, Boutin THD, Chaieb H, Flores PM, Charneau P, Gorochov G, Amoura Z. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus. Ann Rheum Dis 2021:annrheumdis-2021-221097. [PMID: 34607791 DOI: 10.1136/annrheumdis-2021-221097] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Giannella M, Pierrotti LC, Helanterä I, Manuel O. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know. Transpl Int 2021;34:1776-88. [PMID: 34450686 DOI: 10.1111/tri.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lotz C, Herrmann J, Hübsch ME, Notz Q, Meybohm P. [Measurement of Anti-SARS CoV-2 Antibodies following Vaccination: Valuable Monitoring or Irrelevant Tool?]. Anasthesiol Intensivmed Notfallmed Schmerzther 2022;57:302-6. [PMID: 35451036 DOI: 10.1055/a-1783-3932] [Reference Citation Analysis]
57 Vinson AJ, Anzalone AJ, Sun J, Dai R, Agarwal G, Lee SB, French E, Olex A, Ison MG, Mannon RB; N3C consortium. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls. Am J Transplant 2022. [PMID: 35674237 DOI: 10.1111/ajt.17117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Cassaniti I, Gregorini M, Bergami F, Arena F, Sammartino JC, Percivalle E, Soleymaninejadian E, Abelli M, Ticozzelli E, Nocco A, Minero F, Pattonieri EF, Lilleri D, Rampino T, Baldanti F. Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients. Vaccines (Basel) 2022;10:921. [PMID: 35746528 DOI: 10.3390/vaccines10060921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Hamm SR, Møller DL, Pérez-Alós L, Hansen CB, Pries-Heje MM, Heftdal LD, Hasselbalch RB, Fogh K, Madsen JR, Almagro Armenteros JJ, Knudsen AD, Poulsen JR, Frikke-Schmidt R, Hilsted LM, Sørensen E, Ostrowski SR, Harboe ZB, Perch M, Sørensen SS, Rasmussen A, Bundgaard H, Garred P, Iversen K, Nielsen SD. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls. Front Immunol 2022;13:832501. [PMID: 35281023 DOI: 10.3389/fimmu.2022.832501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Loconsole D, Stea ED, Sallustio A, Fontò G, Pronzo V, Simone S, Centrone F, Accogli M, Gesualdo L, Chironna M. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients. Vaccines (Basel) 2021;9:806. [PMID: 34451931 DOI: 10.3390/vaccines9080806] [Reference Citation Analysis]
61 Zong K, Peng D, Yang H, Huang Z, Luo Y, Wang Y, Xiang S, Li T, Mou T, Wu Z. Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis. Front Immunol 2022;13:888385. [DOI: 10.3389/fimmu.2022.888385] [Reference Citation Analysis]
62 Gravetz A, Tennak V, Mezhebovsky V, Gurevich M, Eisner S, Nesher E. Kidney Transplantation during the SARS-CoV-2 Pandemic in Israel: Experience from a Large-Volume Center. Transplantology 2021;2:433-40. [DOI: 10.3390/transplantology2040041] [Reference Citation Analysis]
63 Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep 2021;6:2292-304. [PMID: 34250319 DOI: 10.1016/j.ekir.2021.06.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Ducloux D, Colladant M, Chabannes M, Bamoulid J, Courivaud C. Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients. Clin Kidney J 2021;14:2270-2. [PMID: 34603706 DOI: 10.1093/ckj/sfab125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Firinu D, Fenu G, Sanna G, Costanzo GA, Perra A, Campagna M, Littera R, Locci C, Marongiu A, Cappai R, Melis M, Orrù G, Del Giacco S, Coghe F, Manzin A, Chessa L. Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy. J Autoimmun 2022;131:102848. [PMID: 35714496 DOI: 10.1016/j.jaut.2022.102848] [Reference Citation Analysis]
67 Buchwinkler L, Solagna CA, Messner J, Pirklbauer M, Rudnicki M, Mayer G, Kerschbaum J. Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation. J Clin Med 2021;11:148. [PMID: 35011888 DOI: 10.3390/jcm11010148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Sigler R, Chen V, Law N. Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients. Curr Transplant Rep 2022;:1-14. [PMID: 35669887 DOI: 10.1007/s40472-022-00368-z] [Reference Citation Analysis]
69 Sakhi H, Chavarot N, Attias P, El Karoui K, Anglicheau D. [COVID-19 vaccination in dialysis and kidney transplant patients]. Nephrol Ther 2021;17:208-13. [PMID: 34305020 DOI: 10.1016/j.nephro.2021.06.005] [Reference Citation Analysis]
70 Kermond RF, Ozimek-Kulik JE, Kim S, Alexander SI, Hahn D, Kesson A, Wood N, McCarthy HJ, Durkan AM. Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients. Pediatr Nephrol 2022. [PMID: 35833990 DOI: 10.1007/s00467-022-05679-y] [Reference Citation Analysis]
71 Tau N, Manuel O, Rozen-Zvi B, Shargian L, Yahav D. Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all? Clin Microbiol Infect 2021:S1198-743X(21)00463-8. [PMID: 34391930 DOI: 10.1016/j.cmi.2021.08.006] [Reference Citation Analysis]
72 Beilhack G, Monteforte R, Frommlet F, Gaggl M, Strassl R, Vychytil A. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Front Immunol 2021;12:780594. [PMID: 34925359 DOI: 10.3389/fimmu.2021.780594] [Reference Citation Analysis]
73 Ma BM, Tam AR, Chan KW, Ma MKM, Hung IFN, Yap DYH, Chan TM. Immunogenicity and Safety of COVID-19 Vaccines in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2022;9:827859. [PMID: 35355604 DOI: 10.3389/fmed.2022.827859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Reischig T, Kacer M, Vlas T, Drenko P, Kielberger L, Machova J, Topolcan O, Kucera R, Kormunda S. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. Am J Transplant 2021. [PMID: 34860470 DOI: 10.1111/ajt.16902] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
75 Malik SA, Modarage K, Goggolidou P. A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals. F1000Res 2022;11:909. [DOI: 10.12688/f1000research.122820.1] [Reference Citation Analysis]
76 Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, Asayag H, Aharon M, Burstein I, Pri-Chen H, Imam A, Abel R, Mor-Yosef Levi I, Khalaileh A, Oiknine-Djian E, Bloch A, Wolf DG, Dranitzki Elhalel M. Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up. J Nephrol 2022. [PMID: 34988942 DOI: 10.1007/s40620-021-01210-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
77 Kantauskaite M, Müller L, Kolb T, Fischer S, Hillebrandt J, Ivens K, Andree M, Luedde T, Orth HM, Adams O, Schaal H, Schmidt C, Königshausen E, Rump LC, Timm J, Stegbauer J. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. Am J Transplant 2021. [PMID: 34551181 DOI: 10.1111/ajt.16851] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 28.0] [Reference Citation Analysis]
78 Al Jurdi A, Gassen RB, Borges TJ, Solhjou Z, Hullekes FE, Lape IT, Efe O, Alghamdi A, Patel P, Choi JY, Mohammed MT, Bohan B, Pattanayak V, Rosales I, Cravedi P, Kotton CN, Azzi JR, Riella LV. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination. Front Immunol 2022;13:838985. [PMID: 35281011 DOI: 10.3389/fimmu.2022.838985] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
79 Feingold B, Berman P, Moninger A, Huston A, Stinner B, West SC, Rose-Felker K, Zinn MD, Miller SA, Michaels MG. Responsiveness to second and third dose of mRNA COVID-19 vaccination in adolescent and young adult heart transplant recipients. Pediatr Transplant 2022;:e14272. [PMID: 35340096 DOI: 10.1111/petr.14272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Chen P, Söderdahl G, Österborg A, Smith CIE, Wullimann D, Vesterbacka J, Lindgren G, Blixt L, Friman G, Wahren-Borgström E, Nordlander A, Gomez AC, Akber M, Valentini D, Norlin AC, Thalme A, Bogdanovic G, Muschiol S, Nilsson P, Hober S, Loré K, Chen MS, Buggert M, Ljunggren HG, Ljungman P, Aleman S; COVAXID-collaborator group (shown separately). Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. EBioMedicine 2021;74:103705. [PMID: 34861491 DOI: 10.1016/j.ebiom.2021.103705] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Davidov Y, Tsaraf K, Cohen-Ezra O, Likhter M, Ben Yakov G, Levy I, Levin EG, Lustig Y, Mor O, Rahav G, Ben Ari Z. Immunogenicity and Adverse Effect of Two Dose BNT162b2 mRNA Vaccine Among Liver Transplant Recipients. Liver Transpl 2021. [PMID: 34767690 DOI: 10.1002/lt.26366] [Reference Citation Analysis]
82 Henderson DK, Haessler S, Weber DJ. The coronavirus disease 2019 (COVID-19) pandemic-Looking back and looking forward. Infect Control Hosp Epidemiol 2021;:1-6. [PMID: 34334144 DOI: 10.1017/ice.2021.338] [Reference Citation Analysis]
83 Sood A, Tran M, Murthy V, Gonzalez E. Immunogenicity and Safety of SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases: A Systematic Review and Meta-analysis. J Clin Rheumatol 2022. [PMID: 35660717 DOI: 10.1097/RHU.0000000000001871] [Reference Citation Analysis]
84 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]